FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Eversense 365 Continuous Glucose Monitoring (CGM) System
K Number: K241335
·
Decision Sep 16, 2024
Classifications
1
FEI Numbers
4
Registration Numbers
4
Same Product Code
1
Applicant Total
2
Review Days
126
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Eversense 365 Continuous Glucose Monitoring (CGM) System
- K Number
- K241335
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.1357
- Medical Specialty
- Clinical Chemistry
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Senseonics, Incorporated
- Date Received
- May 13, 2024
- Decision Date
- September 16, 2024
- Product Code
- SBA
- Advisory Committee
- Clinical Chemistry
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| SBA | Integrated Continuous Glucose Monitoring System With Sensor Containing Dexamethasone Acetate | FDA class 2 | Clinical Chemistry |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (SBA), ordered by most recent decision date.
View allOther Clearances by Senseonics, Incorporated
| K Number | Device Name | ||
|---|---|---|---|
| DEN230052 | Eversense AP CGM System | Apr 29, 2024 | Unknown |